Immunovant, Inc. (IMVT) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$25.04
Day's range
$26.84

Immunovant Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 05/15/2026 16.95 M $420.99 M   -0.25% 9.34%
DEEP TRACK CAPITAL, LP 05/15/2026 11.53 M $286.33 M   0.00% 6.35%
BLACKROCK, INC. 05/13/2026 6.57 M $163.31 M   8.52% 3.62%
BAKER BROS. ADVISORS LP 05/15/2026 5.46 M $135.57 M   0.00% 3.01%
STATE STREET CORP 05/15/2026 4.54 M $112.72 M   19.83% 2.50%
TCG CROSSOVER MANAGEMENT, LLC 05/15/2026 4.46 M $110.74 M   168.40% 2.46%
MORGAN STANLEY 05/15/2026 3.88 M $96.30 M   -20.00% 2.14%
05/08/2026 3.70 M $92.03 M   100.00% 2.04%
05/15/2026 3.62 M $89.92 M   100.00% 1.99%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 05/15/2026 3.61 M $89.74 M   -28.61% 1.99%
ARMISTICE CAPITAL, LLC 05/15/2026 3.56 M $88.55 M   -37.97% 1.96%
TWO SEAS CAPITAL LP 05/15/2026 3.20 M $79.54 M   11.68% 1.76%
JENNISON ASSOCIATES LLC 05/06/2026 3.20 M $79.41 M   356.37% 1.76%
RTW INVESTMENTS, LP 05/15/2026 3.18 M $78.94 M   0.00% 1.75%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 2.68 M $66.55 M   7.98% 1.48%
ALPINE GLOBAL MANAGEMENT, LLC 05/15/2026 2.64 M $65.50 M   0.39% 1.45%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 2.09 M $51.98 M   12.63% 1.15%
WOODLINE PARTNERS LP 05/15/2026 1.98 M $49.08 M   0.00% 1.09%
ARMISTICE CAPITAL, LLC 05/15/2026 1.90 M $47.20 M   153.33% 1.05%
GOLDMAN SACHS GROUP INC 05/15/2026 1.79 M $44.34 M   37.74% 0.98%
PERCEPTIVE ADVISORS LLC 05/29/2026 1.60 M $39.68 M   -19.93% 0.88%
FARALLON CAPITAL MANAGEMENT LLC 05/15/2026 1.55 M $38.40 M   12,783.33% 0.85%
ABRDN PLC 04/29/2026 1.16 M $28.83 M   -1.97% 0.64%
LOGOS GLOBAL MANAGEMENT LP 05/15/2026 1.08 M $26.70 M   -21.82% 0.59%
BANK OF AMERICA CORP /DE/ 05/18/2026 893.68 K $22.20 M   185.08% 0.49%
STEMPOINT CAPITAL LP 05/18/2026 746.49 K $18.54 M   15.74% 0.41%
UBS GROUP AG 05/05/2026 684.55 K $17.00 M   -6.53% 0.38%
CANDRIAM S.C.A. 04/30/2026 680.37 K $16.90 M   0.00% 0.37%
NORTHERN TRUST CORP 05/14/2026 672.77 K $16.71 M   18.83% 0.37%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 660.44 K $16.41 M   2.72% 0.36%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 617.81 K $15.35 M   138.43% 0.34%
GREAT POINT PARTNERS LLC 05/15/2026 545.63 K $13.55 M   -27.25% 0.30%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 544.54 K $13.53 M   100.00% 0.30%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/11/2026 503.67 K $12.51 M   7.74% 0.28%
PICTET ASSET MANAGEMENT HOLDING SA 04/22/2026 472.38 K $11.73 M   24.04% 0.26%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 465.90 K $11.57 M   178.48% 0.26%
SILVERARC CAPITAL MANAGEMENT, LLC 05/14/2026 414.24 K $10.29 M   100.00% 0.23%
05/15/2026 414.05 K $10.29 M   72.40% 0.23%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 413.00 K $10.26 M   -52.14% 0.23%
SUPERSTRING CAPITAL MANAGEMENT LP 05/14/2026 357.61 K $8.88 M   23.88% 0.20%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 339.61 K $8.44 M   -61.97% 0.19%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 334.56 K $8.31 M   -5.24% 0.18%
GRANAHAN INVESTMENT MANAGEMENT, LLC 05/15/2026 244.43 K $6.07 M   6.19% 0.13%
NUVEEN, LLC 04/30/2026 241.20 K $5.99 M   6.49% 0.13%
SOLEUS CAPITAL MANAGEMENT, L.P. 05/14/2026 230.00 K $5.71 M   -79.28% 0.13%
HIGHVISTA STRATEGIES LLC 05/15/2026 225.14 K $5.59 M   1.47% 0.12%
TFG ASSET MANAGEMENT GP LTD 05/15/2026 218.51 K $5.43 M   31.48% 0.12%
BANK OF NEW YORK MELLON CORP 05/05/2026 216.23 K $5.37 M   8.46% 0.12%
ASSENAGON ASSET MANAGEMENT S.A. 04/20/2026 205.22 K $5.10 M   0.00% 0.11%
XTX TOPCO LTD 05/15/2026 203.03 K $5.04 M   512.97% 0.11%

Immunovant Inc institutional Ownership - FAQ's

During the previous two years, 264 institutional investors and hedge funds held shares of Immunovant Inc. The most heavily invested institutionals were:

FMR LLC: 16.95 M

Deep Track Capital, LP: 11.53 M

BlackRock, Inc.: 6.57 M

BAKER BROS. ADVISORS LP: 5.46 M

STATE STREET CORP: 4.54 M

TCG Crossover Management, LLC: 4.46 M

60.93% of Immunovant Inc stock is owned by institutional investors.

Institutional investors have bought a total of 120.79 M shares in the last 24 months. This purchase volume represents approximately $3.19 B in transactions.